The US federal government has cleared the proposed sale of California-based Complete Genomics to China's BGI-Shenzen, The New York Times reports. The acquisition was given the OK by Committee on Foreign Investment in the United States, which examines the national security ramification of sales of US companies to foreign buyers. The Times adds that the Federal Trade Commission still needs to green-light the deal on antitrust grounds.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.